Indirect Immunofluorescent assay, RIA, Western blot, Cell Binding assay
Evaluating new onset encephalopathy (noninfectious or metabolic) comprising confusional states, psychosis, delirium, memory loss, hallucinations, movement disorders, sensory or motor complaints, seizures, dyssomnias, ataxias, nausea, vomiting, inappropriate antidiuresis, coma, dysautonomias, or hypoventilation in serum specimens
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
7 - 11 days